MAPT and early-onset autosomal dominant Alzheimer disease: CSF tau phosphorylated at threonine 181 (pTau181) is one of the core biomarkers incorporated into the National Institute on Aging—Alzheimer's Association Research Framework to define Alzheimer's disease.